2018-19 Section 7-Neoplastic and Inflammatory Diseases of the Head and Neck eBook

|

CHERAGHLOU ET AL .

TABLE 1

Characteristics of the study population

No. of patients (%)

Early-stage without adverse features (n 5 1138)

Early-stage with adverse features (n 5 2966)

Late-stage without adverse features (n 5 118)

Late-stage with adverse features (n 5 4358)

Total (n 5 8580)

Variables

Patient factors

Age, years 50

2294 (26.7) 1817 (21.2) 1805 (21.0) 2664 (31.0)

503 (44.2) 276 (24.2) 187 (16.4) 172 (15.1)

963 (32.5) 637 (21.5) 601 (20.3) 765 (25.8)

38 (32.2) 24 (20.3) 26 (22.0) 30 (25.4)

790 (18.1) 880 (20.2) 991 (22.7) 1697 (38.9)

51-60 61-70

> 70

Sex

Female

3747 (43.7) 4833 (56.3)

682 (59.9) 456 (40.1)

1499 (50.5) 1467 (49.5)

55 (46.6) 63 (53.4)

1511 (34.7) 2847 (65.3)

Male

Race

White Black

6836 (79.7) 862 (10.0)

830 (72.9) 171 (15.0)

2320 (78.2) 311 (10.5)

76 (64.4) 21 (17.8) 12 (10.2)

3610 (82.8)

359 (8.2) 168 (3.8) 121 (2.8) 100 (2.3)

Hispanic

363 (4.2) 301 (3.5) 218 (2.5)

49 (4.3) 53 (4.7) 35 (3.1)

134 (4.5) 120 (4.0) 81 (2.7)

Asian/Pacific Islander

7 (5.9) 2 (1.7)

Other

Charlson/Deyo score 0

7080 (82.5) 1214 (14.2)

977 (85.8) 137 (12.0)

2515 (84.8) 373 (12.6)

99 (83.9) 15 (12.7)

3489 (80.1) 689 (15.8)

1

2

286 (3.3)

24 (2.1)

78 (2.6)

4 (3.4)

180 (4.1)

System factors

Insurance status Private

4158 (48.5) 3987 (46.5)

733 (64.4) 351 (30.8)

1601 (54.0) 1218 (41.1)

60 (50.8) 54 (45.8)

1764 (40.5) 2364 (54.2)

Government

None

284 (3.3) 151 (1.8)

30 (2.6) 24 (2.1)

102 (3.4) 45 (1.5)

3 (2.5) 1 (0.8)

149 (3.4) 81 (1.9)

Unknown

Facility type Academic

3274 (38.2) 5306 (61.8)

377 (33.1) 761 (66.9)

993 (33.5) 1973 (66.5)

53 (44.9) 65 (55.1)

1851 (42.5) 2507 (57.5)

Other/unknown

Tumor factors

T classification 1

2719 (31.7) 2493 (29.1) 1874 (21.8) 1494 (17.4)

770 (67.7) 368 (32.3)

1524 (51.4) 1442 (48.6)

425 (9.8) 683 (15.7) 1785 (41.0) 1465 (33.6)

. . . . . .

2 3 4

89 (75.4) 29 (24.6)

. . . . . .

. . . . . .

N classification 0

5788 (67.5) 1081 (12.6) 1685 (19.6)

1138 (100.0)

2966 (100.0)

118 (100.0)

1566 (35.9) 1081 (24.8) 1685 (38.7)

1 2 3

. . . . . . . . .

. . . . . . . . .

. . . . . . . . .

26 (0.3)

26 (0.6)

(Continues)

48